The cryopyrin-associated periodic syndromes (CAPS) represent the prototypic IL-1-mediated disease, and the IL-1β overproduction is a consequence of gain-of-function NLRP3 variants that ultimately provoke a hyperactivation of the Nlrp3-inflammasome (20, 21). The gene discussed is IL1A; the disease is cryopyrin-associated periodic syndrome.